Company intelligence / Profile preview

Wellgem Biopharma

Vilnius, Vilnius, Lithuaniawellgem.com ↗

Ownership: Private
Employees: ~22
Development stage: Preclinical

Overview

As a service provider/CDMO, Wellgem Biopharma does not appear to have its own clinical pipeline or results. It supports client programs from preclinical through commercialization with process development, GMP supply, and quality control services.

Modalities: Microbial-origin biologicsMammalian-origin biologicsCell and gene therapy (planned)
Industry: Contract Manufacturing Organization

Partnerships

MasterControl (quality management software partnership)

Beyond the preview

Go deeper on Wellgem Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wellgem Biopharma.

Explore the full profile